Michael R. Barer
- Infectious Diseases top 0.5%
- Epidemiology top 1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 2%
- Ecology top 2%
- Co-authors
- Colin R. HarwoodChristopher E. BrightlingMona BafadhelNatalie J. GartonDieter WeichartArseny S. KaprelyantsDouglas B. KellP.T. Kimmitt
- Topics
- Tuberculosis Research and Epidemiology (31 papers)Mycobacterium research and diagnosis (31 papers)Healthcare Policy and Management (15 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Michael R. Barer
155 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Infectious Diseases 1.8k
- Epidemiology 1.7k
- Molecular Biology 1.6k
- Pulmonary and Respiratory Medicine 1.3k
- Ecology 1.1k
Countries citing papers authored by Michael R. Barer
This map shows the geographic impact of Michael R. Barer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Barer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Barer more than expected).
Fields of papers citing papers by Michael R. Barer
This network shows the impact of papers produced by Michael R. Barer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Barer. The network helps show where Michael R. Barer may publish in the future.
Co-authorship network of co-authors of Michael R. Barer
This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Barer. A scholar is included among the top collaborators of Michael R. Barer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Barer. Michael R. Barer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 21 | |
| 4 | 14 | |
| 5 | 143 | |
| 6 | 83 | |
| 7 | 0 | |
| 8 | 6 | |
| 9 | 15 | |
| 10 | Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled Trialbreakdown → | 422 |
| 11 | 203 | |
| 12 | 34 | |
| 13 | 313 | |
| 14 | 8 | |
| 15 | 28 | |
| 16 | 58 | |
| 17 | 458 | |
| 18 | Common Problems, Different "Solutions": Learningfrom International Approaches to Improving MedicalServices Access for Underserved Populations | 1 |
| 19 | 1 | |
| 20 | 11 |
About Michael R. Barer
Michael R. Barer is a scholar working on Medical Terminology, Endocrinology and Infectious Diseases, having authored 169 papers that have together received 6.9k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (31 papers), Mycobacterium research and diagnosis (31 papers) and Healthcare Policy and Management (15 papers). The work is most often cited by research in Endocrinology (824 citations), Infectious Diseases (1.8k citations) and Molecular Medicine (366 citations). Michael R. Barer has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Colin R. Harwood, Christopher E. Brightling, Mona Bafadhel, Natalie J. Garton, Dieter Weichart, Arseny S. Kaprelyants, Douglas B. Kell, P.T. Kimmitt, Rory P. Cooney and Richard A. Adegbola. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.